Simcere Pharmaceutical Group Limited Stock
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
07:08:08 30/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 10.14 HKD | -2.31% |
|
-5.14% | -15.29% |
| 20/10 | Roche Partners With China's Hansoh in Deal That Could Top $15 Billion -- Update | DJ |
| 20/10 | Major drugmakers turn to China for licensing deals | RE |
| Market Cap | 3.4B 26.66B 3.04B 2.81B 2.54B 4.75B 324B 4.83B 33.49B 13.36B 169B 12.75B 12.48B 536B | P/E 2026 * |
12.8x | P/E 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.2B 25.11B 2.87B 2.64B 2.39B 4.47B 305B 4.55B 31.55B 12.59B 159B 12.01B 11.75B 505B | EV / Sales 2026 * |
2.12x | EV / Sales 2027 * | 1.85x |
| Free-Float |
33.7% | Yield 2026 * |
4.09% | Yield 2027 * | 4.64% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2096 | Delayed | |
OTC Markets
| SMHGF | Delayed | |
|
Tradegate
| S2P | Real-time | |
|
Deutsche Boerse AG
| S2P | Delayed | |
|
Börse Stuttgart
| S2P | Delayed | |
|
Boerse Muenchen
| S2P | Real-time |
| 1 day | -2.31% | ||
| 1 week | -5.14% | ||
| Current month | -14.43% | ||
| 1 month | -14.43% | ||
| 3 months | -18.94% | ||
| 6 months | -14.36% | ||
| Current year | -15.29% |
| 1 week | 10.04 |  | 10.98 |
| 1 month | 10.04 | | 11.8 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 14.38 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CEO | Chief Executive Officer | 63 | 20/08/2026 |
Yunshu Zhou
CEO | Chief Executive Officer | 54 | 25/03/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 19/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 08/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 19/11/2019 |
Renhong Tang
BRD | Director/Board Member | 46 | 01/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/8/26 | Other | Chairperson | -3,000,000 | 0.1168% | ||
| 13/7/26 | Other | Founder | -47,000 | 0.0018% | ||
| 13/7/26 | Other | Director | -47,000 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.31% | -5.14% | -14.43% | +48.03% | 3.4B | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,224B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 662B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 514B | |
| +0.37% | +3.15% | +54.07% | +67.09% | 388B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 361B | |
| +1.12% | +4.33% | +35.05% | +57.79% | 302B | |
| +4.18% | +5.82% | +8.16% | +32.80% | 271B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 249B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 205B | |
| Average | +1.77% | +2.33% | +39.50% | +78.38% | 418.02B | |
| Weighted average by Cap. | +1.92% | +3.04% | +50.70% | +96.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.51B 11.84B 1.35B 1.25B 1.13B 2.11B 144B 2.14B 14.88B 5.94B 75.22B 5.66B 5.54B 238B | 1.76B 13.79B 1.57B 1.45B 1.31B 2.46B 167B 2.5B 17.32B 6.91B 87.57B 6.59B 6.45B 277B |
| Net income | 257M 2.01B 230M 212M 192M 359M 24.44B 365M 2.53B 1.01B 12.79B 963M 943M 40.52B | 303M 2.38B 272M 251M 227M 424M 28.9B 431M 2.99B 1.19B 15.13B 1.14B 1.11B 47.91B |
| Net Debt | -197M -1.55B -177M -163M -148M -276M -18.79B -280M -1.95B -776M -9.83B -740M -725M -31.14B | -140M -1.1B -125M -115M -104M -195M -13.31B -199M -1.38B -550M -6.96B -524M -513M -22.06B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | HKD 10.14 | -2.31% | 4,494,000 |
| 29/10/26 | HKD 10.38 | +0.68% | 4,208,000 |
| 28/10/26 | HKD 10.31 | +1.18% | 9,611,610 |
| 27/10/26 | HKD 10.19 | -3.04% | 9,373,796 |
| 26/10/26 | HKD 10.51 | -1.68% | 3,312,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Select your edition
All financial news and data tailored to specific country editions
